רמיטנס 10

Country: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ixtrih issa

Ingredjent attiv:

RAMIPRIL

Disponibbli minn:

RAFA LABORATORIES LTD

Kodiċi ATC:

C09AA05

Għamla farmaċewtika:

קפסולות

Kompożizzjoni:

RAMIPRIL 10 MG

Rotta amministrattiva:

פומי

Tip ta 'preskrizzjoni:

מרשם נדרש

Manifatturat minn:

RAFA LABORATORIES LTD, JERUSALEM

Grupp terapewtiku:

RAMIPRIL

Żona terapewtika:

RAMIPRIL

Indikazzjonijiet terapewtiċi:

Hypertension congestive heart failure reduction of mortality in patients after MI with left ventricular dysfunction. For reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in patients over 55 years or more who have clinical evidence of cardiovascular disease (previous MI unstable angina or multivessel CABG or multivessel PTCA) stroke or peripheral vascular disease. Also for reducing the risk of myocardial infarction stroke cardiovascular death or need for revascularization procedures in diabetic patients of 55 years or more who have one or more of the following clinical findings : hypertension (systolic blood pressure > 160 mmHg or diastolic pressure > 90 mmHg) high total cholesterol (>5.2 mmol/L) low HDL ( <0.9 mmol/L) current smoker known microalbuminuria clinical evidence of previous vascular disease. Prevention of progressive renal failure in patients suffering from impaired renal function.

Data ta 'l-awtorizzazzjoni:

2014-08-31

Fuljett ta 'informazzjoni

                                1 ״ )
(
-
1986
10
:
10
:
10
(
"
(Ramipril
.
:
6
.
'
'
2
. .
.
,
.
.
.
.
1
.
?
,
,
,)
(
-
,
-
. :
,
ACE
.
2
.
:
−
)
(
ACE
(
6
.)
:
.
,
,
,
,
−
,
:
,
(
urticaria
,)
,
,
,
.
,
−
,
/
-
.
−
,
.
.
−
-
Renal artery stenosis
.
−
.)"
,
"
(
−
.
.
−
.
,
.
.
: ,
:
-
.
,
-
,
,
,
(
.)
,
-
.)
(
-
.
.
;
-
.)
(
-
.
.
,
-
,
mTOR
(
:
,
,
,)
2
(
,
NEP inhibitors
,
)
:
/
."
"
/
.
-
(
systemic lupus erythematosus
)
.
-
.
-
3
.)"
,
"
(
-
:
2
(
angiotensin-II receptor
blockers
sartans
)
,
,
:
,
.
(
,
."
"
.)
:
18
.
,)
(
.
:
, , , ,
.
:
:
-
(
NSAIDs
.)
-
,
,
-
,
,
.
.
:
-
/
-
-
"
(
)"
-
(
NSAIDs
)
-
)
(
-
-
-
,
,
,
,
)
(
)
(
-
-
)
(
-
)
(
-
)
(
-
,
)
(
-
(
2
)
-
)
(
-
/
ARB) II
)
"
(
"
-
.)"
"
:
-
.
,
.
-
.)
(
.
.
,)
(
.
:
.
3
:
.
,
.
: ,
.
-
12
-
13
,
.
,
.
,
.
.
,
.
.
:
.
.
. :
sunset yellow
,
.
3
.
?
.
.
:
.
.
.
.
,
.
.
:
,
.
,
.
:
.
!
. ! .
. , .
4
4
.
,
.
.
.
-
.
-
,
,
-
.
-
,
,
,
,
(
toxic epidermal necrolysis ,Stevens-Johnson
erythema multiforme
.)
:
-
,
(
palpitations
,)
,
.
-
-
.
-
(
,
,
,
,
,)
,
,
,
-
.
-
-
.
-
)
(
,
,
,
,
,
,
-
.
:
.
_ ועפו_
_ _
_ _
_וו_
_ _
_ _
_ _
_וח_
_ _
_ _
_וע פו(_
_1-10_
_ _
_ _
_ _
_ו_
_ _
_100_
_)_
_ _
_:_
_ _
_ _
-
-
-
-
,
,
-
,
,
-
,
,
,
-
-
-
-
.
_ ועפו_
_ _
_ _
_וו_
_ _
_ _
_ _
_ וח_
_ _
_ _
_(_
_וע פו_
_ _
_ _
_ _
_1-10_
_ _
_ _
_ _
_ _
_ו_
_ _
_1,000_
_ _
_:)_
_ _
-
)
(
-
,
,
,
(
)
-
-
-
,
,
-
,
-
(
intestinal angioedema
)
,
-
,
-
-
-
-
-
-
-
-
5
-
-
-
,
-
(
eosinophilia
)
-
.
,
_ _
_ועפו_
_ _
_וו_
_ _
_ו_
_ד_
_ _
_ _
_(_
_וע פו_
_ _
_ _
_1-10_
_ _
_ _
_ו_
_ _
_ _
_10,000_
_ _
_:)_
_ _
_ _
-
-
-
,
,
-
)
(
-
-
-
-
,
,
-
-
-
,
.
_ _
_ועפו_
_ _
_וו_
_ _
_ _
_ו_
_ד_
_ _
_דו_
_ _
_ _
_ _
_וע פו_
_(_
_ וחפ_
_ _
_ _
_1_
_ _
_ _
_ו_
_10,000_
_ _
_)_
_ _
_:_
_ _
_ _
-
.
:
:
-
-
-
-
-
,
,
,
,)
(
(
ADH
.)
,
-
(
Raynaud’s phenomenon
)
-
-
-
-
-
. ,
. ,
"
"
(
www.health.gov.il
)
:
״
,
HTTPS://SIDEEFFECTS.HEALTH.GOV.IL//
6
5
.
?
!
.
/
.
(
exp. date
)
.
.
:
,
-
25°C
.
6
.
,
:
Starch, gelatin, titanium dioxide, brilliant blue FCF, D&C
                                
                                Aqra d-dokument sħiħ
                                
                            

Dokumenti f'lingwi oħra

Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Ingliż 05-08-2020
Fuljett ta 'informazzjoni Fuljett ta 'informazzjoni Għarbi 05-08-2020

Fittex twissijiet relatati ma 'dan il-prodott

Ara l-istorja tad-dokumenti